Medtronic dives deeper with $20M second tranche investment in Mazor Robotics: 6 takeaways

Spinal Tech

Dublin, Ireland-based Medtronic completed its second tranche investment in Caesarea, Israel-based Mazor Robotics.

Here are six takeaways:

 

1. Mazor issued securities representing 3.4 percent of its issued and outstanding share capital on a fully diluted basis at a price per American Depositary Share $21.84.

 

2. The second tranche investment totals $20 million.

 

3. The announcement of Mazor X Surgical Assurance Platform on July 12 spurred Medtronic to complete this second tranche investment.

 

4. Medtronic has now purchased a total of 1.96 million ADS', accounting for 7.27 percent of Mazor's issued and outstanding share capital on a fully diluted basis. This totals $31.9 million.

 

5. As of June 20, Mazor's cash, cash equivalents and investments reached $47.5 million.

 

6. After the second equity investment, Mazor's cash, cash equivalents and investments will reach $65 million with a fully diluted share count of about 53.9 million.

 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like